Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TYSABRI vs UBLITUXIMAB-XIIY: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TYSABRI vs UBLITUXIMAB-XIIY: Safety Overview

Metric TYSABRI UBLITUXIMAB-XIIY
Total FAERS Reports 8,210 900
Deaths Reported 156 9
Death Rate 1.9% 1.0%
Hospitalizations 1,256 66
Average Patient Age 46.4 yrs 44.8 yrs
% Female Patients N/A 74.8%
Marketing Status N/A Prescription